Hair & Nails
Clinical Review
Imaging Tools for Noninvasive Hair Assessment
We provide an overview of 4 noninvasive hair imaging technologies: global photography, trichoscopy, reflectance confocal microscopy (RCM), and...
Practical Pearls
Affixing a Scalp Dressing With Hairpins
We describe a method for using hairpins to affix a dressing after scalp surgery or trauma that is sturdy, does not compromise aesthetics, and does...
Latest News
Free teledermatology clinic helps underserved patients initiate AD care
The program "is meant to be a stepping point for initiating care ... to set someone up for success for recurrent telehealth visits in the future...
Latest News
Case series supports targeted drugs in treatment of alopecia in children with AD
In children with both alopecia areata and atopic dermatitis, dupilumab alone or in combination is associated with hair regrowth.
Case Letter
Adjuvant Scalp Rolling for Patients With Refractory Alopecia Areata
Dermatologists should be aware of scalp rolling as a safe, affordable, and potentially effective adjuvant to conventional therapy for alopecia...
Latest News
EU agency issues positive opinion on ritlecitinib
In June, ritlecitinib was approved by the FDA for the treatment of severe alopecia areata in adults and adolescents 12 years and older.
Latest News
New guidelines for MTX use in pediatric inflammatory skin disease unveiled
One of the recommendations states that liver biopsy is not indicated for routine monitoring of pediatric patients taking low-dose MTX.
Latest News
Hairy moles may contain the cure for baldness: Study
Researchers analyzed hair follicle stem cells and discovered that a molecule called osteopontin drives accelerated hair growth.
Case Letter
Dyshidroticlike Contact Dermatitis and Paronychia Resulting From a Dip Powder Manicure
To increase clinical awareness of the dip manicure technique, we describe the presentation and successful treatment of dyshidroticlike contact...
News from the FDA/CDC
FDA approves ritlecitinib for ages 12 and up for alopecia areata
It is the second JAK inhibitor approved for treating alopecia areata, following approval of baricitinib (Olumiant) in June 2022 for alopecia...
Latest News
Low-dose oral minoxidil for hair loss soars after NYT article
Dermatologists are increasingly familiar with the medication, but a popular media report seems to have resulted in a quick uptake.